Table 4 |
|||
|
Correlation of changes in IGF-1, pain, and pain threshold, and changes in cerebrospinal markers |
|||
|
ΔIGF-1 (serum) |
ΔPain threshold |
ΔPain |
|
|
|
|||
|
0.495 |
0.539 |
0.075 |
|
|
ΔCSF SP |
P = 0.072 |
P = 0.038 |
P = 0.790 |
|
n = 14 |
n = 15 |
n = 15 |
|
|
|
|||
|
-0.164 |
0.335 |
0.016 |
|
|
ΔCSF NGF |
P = 0.558 |
P = 0.204 |
P = 0.953 |
|
n = 15 |
n = 16 |
n = 16 |
|
|
|
|||
|
0.802 |
0.288 |
0.315 |
|
|
ΔCSF NPY |
P = 0.001 |
P = 0.318 |
P = 0.273 |
|
n = 13 |
n = 14 |
n = 14 |
|
|
|
|||
|
-0.165 |
0.225 |
-0.119 |
|
|
ΔCSF IL-6 |
P = 0.573 |
P = 0.420 |
P = 0.673 |
|
n = 15 |
n = 15 |
n = 15 |
|
|
|
|||
|
-0.164 |
-0.109 |
0.103 |
|
|
ΔCSF IL-8 |
P = 0.558 |
P = 0.688 |
P = 0.704 |
|
n = 15 |
n = 16 |
n = 16 |
|
|
|
|||
|
-0.156 |
-0.579 |
0.329 |
|
|
ΔCSF MMP3 |
P = 0.594 |
P = 0.024 |
P = 0.231 |
|
n = 14 |
n = 15 |
n = 15 |
|
|
|
|||
|
Median and range (min-max) indicated. Spearmans rho(rs), two-tailed significance (P), and number of subjects (n) are presented. |
|||
|
Bjersing et al. Arthritis Research & Therapy 2012 14:R162 doi:10.1186/ar3902 |
|||
